Related Experiment Video
Updated: Mar 9, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy.
Aniket Gad1, Janel Kydd1, Brandon Piel2
1Biomedical Engineering and Biotechnology Program, University of Massachusetts, Lowell, USA.
Polymeric nanoparticles offer a promising solution for cancer treatment by improving chemotherapy delivery. This approach enhances drug efficacy and overcomes resistance, minimizing side effects for better patient outcomes.
Area of Science:
- Nanotechnology
- Oncology
- Materials Science
Background:
- Conventional chemotherapy faces limitations including severe side effects and acquired drug resistance in cancer cells.
- Nanotechnology offers innovative drug delivery systems to overcome these challenges.
- Nanoparticles can improve drug bioavailability, reduce clearance, and enhance efficacy through the enhanced permeability and retention effect.
Purpose of the Study:
- To review recent advancements in using polymeric nanoparticles for combination chemotherapy delivery.
- To explore modifications in nanoparticle delivery parameters that enhance therapeutic efficacy.
- To validate the potential of nanoparticle-based combination therapy for cancer treatment.
Main Methods:
- Utilizing biocompatible and biodegradable polymers for nanoparticle formulation.
- Optimizing nanoparticle properties (size, surface charge, stealth modifications) for improved drug delivery.
- Investigating surface modifications with targeting moieties for enhanced cellular uptake.
- Reviewing in vitro and animal model studies on combination chemotherapy efficacy.
Main Results:
- Polymeric nanoparticles demonstrate potential as effective carriers for chemotherapeutic agents.
- Sustained and controlled drug release from nanoparticles enhances bioavailability and therapeutic effect.
- Combination therapy delivered via nanoparticles shows synergistic cytotoxicity and potential to overcome multidrug resistance.
- Targeted nanoparticle delivery increases drug accumulation in cancer cells, improving efficacy.
Conclusions:
- Polymeric nanoparticles represent a significant advancement in targeted cancer therapy.
- Optimized nanoparticle design and combination chemotherapy can effectively combat drug resistance and improve treatment outcomes.
- This approach holds substantial promise for developing more effective anticancer treatments with reduced collateral damage.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...